However, it is not MHRA-approved and cannot be marketed for human consumption or therapeutic use
Patients should seek urgent medical attention if they experience: Severe or persistent abdominal pain (possible pancreatitis or gallbladder complication) Signs of dehydration (dizziness, reduced urine output) due to vomiting or diarrhoea Symptoms of hypoglycaemia (shakiness, sweating, confusion) or hyperglycaemia (excessive thirst, frequent urination) Severe headache or visual disturbance (possible raised intracranial pressure) Signs of an allergic reaction (rash, swelling, difficulty breathing) Regular monitoring should include fasting glucose, HbA1c, IGF-1, lipid panels, liver function, and renal function
For more information, please reach out to Transportation Director Roberta Atchison at 785-638-2244 or [email protected]
If you also take blood thinners like Xarelto, always inform your prescribing doctor about all medications you use